Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Entrectinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche scrutinized by UK watchdog over 'misleading' Rozlytrek promotional website
    Roche scrutinized by UK watchdog over 'misleading' Rozlytrek promotional website

    21 Sep 2023

    // Nicole DeFeudis ENDPTS

    https://endpts.com/roche-scrutinized-by-uk-watchdog-over-misleading-rozlytrek-promotional-website/

    Nicole DeFeudis ENDPTS
    21 Sep 2023
    Share Share
    FoundationOne Liquid CDx Receives FDA Approval for entrectinib
    FoundationOne Liquid CDx Receives FDA Approval for entrectinib

    04 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230104005548/en

    BUSINESSWIRE
    04 Jan 2023
    Share Share
    Roche's entrectinib gets FDA nod for Foundation Medicine's companion diagnostic
    Roche's entrectinib gets FDA nod for Foundation Medicine's companion diagnostic

    10 Jun 2022

    // Paul Schloesser ENDPTS

    https://endpts.com/roches-ros1-cancer-drug-gets-fda-greenlight-for-foundation-medicines-companion-diagnostic/

    Paul Schloesser ENDPTS
    10 Jun 2022
    Share Share
    Chugai Obtains Approval of FoundationOne CDx Cancer Genomic Profile Rozlytrek
    Chugai Obtains Approval of FoundationOne CDx Cancer Genomic Profile Rozlytrek

    01 Oct 2020

    // PRESS RELEASE

    https://www.chugai-pharm.co.jp/english/news/detail/20190627120000_628.html

    PRESS RELEASE
    01 Oct 2020
    Share Share
    Roche’s Rozlytrek gets EC approval to treat solid tumours and NSCLC
    Roche’s Rozlytrek gets EC approval to treat solid tumours and NSCLC

    04 Aug 2020

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/roche-rozlytrek-ec-approval/

    PHARMACEUTICAL-TECHNOLOGY
    04 Aug 2020
    Share Share
    NICE to recommend Roche cancer treatment
    NICE to recommend Roche cancer treatment

    26 Jun 2020

    // PHARMAFILE

    http://www.pharmafile.com/news/552202/nice-recommend-roche-cancer-treatment

    PHARMAFILE
    26 Jun 2020
    Share Share